Healio (9/13, Rhoades) reported a recent study published in JAMA Network Open found “new laws affecting the recreational or medicinal use of cannabis may be associated with changes in the use of prescription drugs to treat mental health disorders, but these links varied by drug class and state.” Investigators “found an association between medical cannabis laws, when in effect, and a 12.4% reduction in the benzodiazepine fill rate…and 1.3% reduction in the mean number of benzodiazepine fills per patient.” Also, “Specifically, medical cannabis laws were associated with improved self-reported mental health symptoms among older US adults, and recreational cannabis laws were associated with worsened mental health symptoms among younger US adults (≤35 years). Another recent study showed that medical cannabis use was associated with an increased risk of emergency department visits for depressive disorders.”
Related Links:
— “Medical, recreational cannabis laws may impact psychiatric prescription trends,”Andrew (Drew) Rhoades , Healio , September 13, 2024